BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 8401514)

  • 1. A mutation in the 3' untranslated region of the factor IX gene in four families with hemophilia B.
    Vielhaber E; Jacobson DP; Ketterling RP; Liu JZ; Sommer SS
    Hum Mol Genet; 1993 Aug; 2(8):1309-10. PubMed ID: 8401514
    [No Abstract]   [Full Text] [Related]  

  • 2. Characterization of factor IX defects in hemophilia B patients.
    Thompson AR; Chen SH
    Methods Enzymol; 1993; 222():143-69. PubMed ID: 8412791
    [No Abstract]   [Full Text] [Related]  

  • 3. Molecular and functional basis of hereditary factor IX defects.
    Walter J
    Wien Klin Wochenschr; 1994; 106(5):141-3. PubMed ID: 8171870
    [No Abstract]   [Full Text] [Related]  

  • 4. A new hemophilia B mutation in the propeptide region of the FIX gene.
    Chan V; Chan VW; Cherk S; Chan TK
    Am J Hematol; 1995 Oct; 50(2):144-5. PubMed ID: 7572994
    [No Abstract]   [Full Text] [Related]  

  • 5. Molecular characterization of hemophilia B in North Indian families: identification of novel and recurrent molecular events in the factor IX gene.
    Mahajan A; Chavali S; Kabra M; Chowdhury MR; Bharadwaj D
    Haematologica; 2004 Dec; 89(12):1498-503. PubMed ID: 15590401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular analysis of hemophilia B in Poland: 12 novel mutations of the factor IX gene.
    Wulff K; Bykowska K; Lopaciuk S; Herrmann FH
    Acta Biochim Pol; 1999; 46(3):721-6. PubMed ID: 10698280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An A to T transversion at position -5 of the factor IX promoter results in hemophilia B.
    Picketts DJ; D'Souza C; Bridge PJ; Lillicrap D
    Genomics; 1992 Jan; 12(1):161-3. PubMed ID: 1733855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A less severe form of Haemophilia B Leyden.
    Crossley M; Winship PR; Austen DE; Rizza CR; Brownlee GG
    Nucleic Acids Res; 1990 Aug; 18(15):4633. PubMed ID: 2388855
    [No Abstract]   [Full Text] [Related]  

  • 9. Molecular biology of hemophilia B.
    Roberts HR
    Thromb Haemost; 1993 Jul; 70(1):1-9. PubMed ID: 8236083
    [No Abstract]   [Full Text] [Related]  

  • 10. Haemophilia B Leyden arising de novo by point mutation in the putative factor IX promoter region.
    Royle G; Van de Water NS; Berry E; Ockelford PA; Browett PJ
    Br J Haematol; 1991 Feb; 77(2):191-4. PubMed ID: 2004020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Twenty-four novel hemophilia B mutations revealed by rapid scanning of the whole factor IX gene in a French population sample.
    Ghanem N; Costes B; Martin J; Vidaud M; Rothschild C; Foyer-Gazengel C; Goossens M
    Eur J Hum Genet; 1993; 1(2):144-55. PubMed ID: 8055323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel mutation (Val-373 to Glu) in the catalytic domain of factor IX, resulting in moderately/severe hemophilia B in a southern French patient.
    Aguilar-Martinez P; Romey MC; Gris JC; Schved JF; Demaille J; Claustres M
    Hum Mutat; 1994; 3(2):156-8. PubMed ID: 8199596
    [No Abstract]   [Full Text] [Related]  

  • 13. Detection of ten new mutations by screening the gene encoding factor IX of Danish hemophilia B patients.
    Nielsen LR; Scheibel E; Ingerslev J; Schwartz M
    Thromb Haemost; 1995 May; 73(5):774-8. PubMed ID: 7482402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factor IX mutations: rapid, direct screening methods for 20 new families with hemophilia B.
    Thompson AR; Schoof JM; Weinmann AF; Chen SH
    Thromb Res; 1992 Jan; 65(2):289-95. PubMed ID: 1579901
    [No Abstract]   [Full Text] [Related]  

  • 15. Five novel factor IX mutations in unrelated hemophilia B families.
    Chen SH; Schoof JM; Scott CR; Thompson AR
    Hum Mol Genet; 1993 May; 2(5):599-600. PubMed ID: 8518801
    [No Abstract]   [Full Text] [Related]  

  • 16. Haemophilia B Liverpool: a new British family with mild haemophilia B associated with a -6 G to A mutation in the factor IX promoter.
    Stowell KM; Figueiredo MS; Brownlee GG; Jones P; Bolton-Maggs PH
    Br J Haematol; 1993 Sep; 85(1):188-90. PubMed ID: 8251390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The rates of G:C-->T:A and G:C-->C:G transversions at CpG dinucleotides in the human factor IX gene.
    Ketterling RP; Vielhaber E; Sommer SS
    Am J Hum Genet; 1994 May; 54(5):831-5. PubMed ID: 8178822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Splice junction mutations in factor IX gene resulting in severe hemophilia B.
    Chen SH; Zhang M; Thompson AR; Bray GL; Scott CR
    Nucleic Acids Res; 1991 Mar; 19(5):1172. PubMed ID: 2020563
    [No Abstract]   [Full Text] [Related]  

  • 19. Twenty-five novel mutations of the factor IX gene in haemophilia B.
    Wulff K; Schröder W; Wehnert M; Herrmann FH
    Hum Mutat; 1995; 6(4):346-8. PubMed ID: 8680410
    [No Abstract]   [Full Text] [Related]  

  • 20. Age-specific regulation of clotting factor IX gene expression in normal and transgenic mice.
    Boland EJ; Liu YC; Walter CA; Herbert DC; Weaker FJ; Odom MW; Jagadeeswaran P
    Blood; 1995 Sep; 86(6):2198-205. PubMed ID: 7662969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.